Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial

OBJECTIVE: We evaluated whether the increasing number of genetic loci for coronary artery disease (CAD) identified in the general population could be used to predict the risk of major CAD events (MCE) among participants with type 2 diabetes at high cardiovascular risk. RESEARCH DESIGN AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, Mario Luca, Gao, He, Pigeyre, Marie, Shah, Hetal S., Sjaarda, Jennifer, Mendonca, Christine, Hastings, Timothy, Buranasupkajorn, Patinut, Motsinger-Reif, Alison A., Rotroff, Daniel M., Sigal, Ronald J., Marcovina, Santica M., Kraft, Peter, Buse, John B., Wagner, Michael J., Gerstein, Hertzel C., Mychaleckyj, Josyf C., Parè, Guillaume, Doria, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196830/
https://www.ncbi.nlm.nih.gov/pubmed/30262460
http://dx.doi.org/10.2337/dc18-0709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196830/
https://www.ncbi.nlm.nih.gov/pubmed/30262460
http://dx.doi.org/10.2337/dc18-0709

Ejemplares similares